Sam Rasty - Chief Business Officer @ Sensorium Therapeutics

Overview

CB Rank (Person)

Primary Job Title Chief Business Officer
Primary Organization
Sensorium Therapeutics

Location Boston, Massachusetts, United States
Regions Greater Boston Area, East Coast, New England
Gender Male

LinkedIn View on LinkedIn

Sam Rasty is the current Chief Business Officer of Sensorium Therapeutics. He previously worked at Sequence Bio as an Interim CEO. Sam Rasty attended the University of Pittsburgh School of Medicine.

Jobs

Number of Current Jobs

Number of Past Jobs

Sam Rasty

has

current jobs including

Chief Business Officer

Sensorium Therapeutics

Entrepreneur-in-Residence

Yale Ventures

, and

Chief Executive Officer and Board Director

Sequence Bio

. Additionally,

Sam Rasty

has had

past jobs including

President & Chief Executive Officer

Platelet BioGenesis

Sensorium Therapeutics Chief Business OfficerApr 2024
Yale Ventures Entrepreneur-in-ResidenceOct 2023
Sequence Bio Chief Executive Officer and Board DirectorJan 2023

Organization Name	Title At Company	Start Date	End Date
Platelet BioGenesis	President & Chief Executive Officer	Jul 2019	Mar 2022
Homology Medicines	Chief Operating Officer	Jan 2016	Jul 2019
Shire	Vice President and Head of New Products	Aug 2011	Jan 2016
Endo Pharmaceuticals	Director, Corporate Development	Feb 2010	Jul 2011
Endo Pharmaceuticals	Director, Strategic Marketing	Feb 2008	Feb 2010

Board and Advisor Roles

Number of Past Board & Advisor Roles

Organization Name	Title At Company	Start Date	End Date
Platelet BioGenesis	Board Director	Jul 2019	Mar 2022

Related Hubs

Hub Name	CB Rank (Hub)
Massachusetts Early Stage Companies With Less Than $10M in Revenue	65,590
New England Medical Companies	13,558
Boston Companies With More Than 10 Employees	11,867
Greater Boston Area Early Stage Companies With Less Than $500M in Revenue	60,133
Massachusetts Startups Founded in 2021	83,433
Medical Early Stage Companies With Less Than $500M in Revenue	40,328
Massachusetts General Hospital Alumni Founded Companies	80,775
Sante Ventures Portfolio Companies	87,095
Massachusetts Early Stage Companies With Less Than $50M in Revenue	59,886
Therapeutics Early Stage Companies With Less Than $1B in Revenue	64,051